Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Inj BUTORPHANOL: Inj BUTORPHANOL given intravenously in patients who develop shivering over a period of 10 mins.The attending anesthesiologist recorded the time in minutes at which shiv
Sponsors
Dr Ritin Saxena
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade 1 or 2 fit patients. Patient undergooing surgeries under spinal anaesthesia. Haemodynamically stable patients with all routine investigations Within normal limits without any other comorbidities. patients who are not on any cardiac related drugs. availability of written informed consent from concerned patient
Exclusion criteria
Exclusion criteria: Patients not willing to get enrolled in this study. Patients with ASA physical status III or more. Patients below 18 years and above 60 years of age. Patients posted for emergency procedures. Patients with uncontrolled systemic disorders like diabetes mellitus, heart disease, chronic hypertension, pulmonary disorders, etc. Patients with spine deformities or local skin interactions overlying the lumbar vertebral region. Patients with bleeding or coagulation disorders. Patients with known allergies to the study drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and haemodynamic effects of Butorphanol and Tramadol, for the control of Post-Spinal Anaesthesia ShiveringTimepoint: After administering Sub arachnoid block; 0, 1, 2, 5, 10, 15 and 30 minutes after administering the test drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of Butorphanol & Tramadol in sub arachnnoid block.Timepoint: After administering Sub arachnoid block. | — |
Countries
India
Contacts
Public ContactDr Subha Teresa Jose Vazhakalayil
DR. D.Y.PATIL MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, PIMPRI, PUNE
Outcome results
None listed